Bio Applied Technologies Joint — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

BATJ is a privately-held, U.S.-owned service provider in the biotechnology sector, founded in 2005 and headquartered in San Diego. The company operates a fee-for-service business model, offering a suite of sequencing (Sanger, NGS, TGS) and molecular biology services (DNA prep, mutagenesis, cloning) to research clients. Its strategic positioning as a U.S.-owned entity allows it to access non-dilutive government funding, while its strict confidentiality agreements appeal to clients concerned with IP security. BATJ appears to be an early-revenue stage company competing on price and service within the research tools and services market.

Drug DeliveryBiologics

Technology Platform

Integrated service platform offering Sanger, Next-Generation (Illumina, Ion Torrent), and Third-Generation sequencing, plus molecular biology services (DNA prep, mutagenesis, cloning) and related kit products.

Opportunities

Growing demand for outsourced sequencing from academic and small biotech clients provides a stable market.

Eligibility for U.S.

SBIR/STTR grants offers a source of non-dilutive funding for service development.

A strong emphasis on client IP protection is a key differentiator in a trust-sensitive industry.

Risk Factors

High competition in commoditized sequencing services from large, well-funded players and academic core facilities.

Requires continuous capital investment to keep pace with rapid technological obsolescence in sequencing platforms.

Revenue is vulnerable to fluctuations in research funding cycles for its core client base.

Competitive Landscape

BATJ competes in the fragmented life science research services market against large global CROs (e.g., Azenta, Charles River Labs' Discovery Services), specialized sequencing service providers, and university core facilities. It likely competes on price, turnaround time, customer service, and its strong confidentiality provisions, rather than proprietary technology.

More companies in Biologics / Biosimilars →More companies in United States →